NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-08-31
Reading WAT? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Intact: The reason to own it still holds.
Waters Corporation grows revenue over 50% year on year, driven by acquisitions. The company raised full-year 2026 revenue guidance to about $6.42 billion. Adjusted EPS guidance is strong at about $14.5 per share. The acquisition of Becton, Dickinson assets adds $520 million revenue in Q1, boosting growth.
Growth may slow if integration of acquisitions falters. Profit margins could weaken if costs rise. The stock trades expensive with a PE of 27.6, risking valuation pressure if growth disappoints.
The price is about 13% above our fair value near $334 and 16% below the Street median target of $400. Analysts expect 53% revenue growth, which is reflected in the valuation. Our view aligns with this growth but is more conservative than the Street.
Breaks if: Adjusted EPS falls below $13.5 per share
Breaks if: BD asset revenue falls below $480 million in any quarter
Full-year revenue falls below $6.0 billion
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a durable compounder with a focus on steady growth. The current thesis state is intact, supported by strong recent financial performance and management's consistent upward guidance revisions.
The market seems to expect continued growth, as WAT is priced at a premium compared to its peers. There is a slight expectations gap, indicating that while the company is performing well, some growth may already be factored into its valuation.
Fundamentals are likely to remain strong given management's focus on increasing revenue and earnings guidance. However, there is a moderate risk due to the potential for economic downturns and the company's recent history of earnings misses.
The thesis hinges on the performance of sector bellwethers and whether WAT can maintain its growth trajectory. Additionally, any changes in guidance during the next earnings call could significantly impact sentiment.
The most important moves since the prior daily snapshot.
Signal changed from 'mixed' to 'mild_favorable'.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats impacting the thesis.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1-3 years, WAT's performance will depend on its ability to navigate sector dynamics and maintain strong execution. Not investment advice.
